|
|
SABPA Newsletter (March 2009)
| |
 |
|
 |
| Date: |
2009-04-05 |
| Type: |
Newsletter |
| Organizer: |
SABPA |
| Location: |
San Diego |
| Source: |
SABPA |
|
|
|
|
1. The 7th SABAP Science & Technology Forum (3/21/2009, UCSD)
2. The 4th SABPA OC/LA Annual Biomedical Forum (March 28, 2009)
3. The 4th SABPA Professional and Personal Development series
4. The 3rd SABPA Entrepreneur Symposium
5. IBC’s China 2009 Pharmaceutical R&D Summit (4/7-4/9/2009 Shanghai)
7. The Scientist Magazine Exclusive China Supplement Media Opportunity
8. Multiple Job listing
1. The 7th SABAP Science & Technology Forum (3/21/2009, UCSD)
The 7th SABAP Science & Technology Forum was held at the Institute of Americas, UCSD on March 21, 2009. This symposium attracted more than 200 attendees from San Diego and Orange County. The Forum was focused on some of the hottest topics in today’s biomedical field: biomarker, pharmacogenomics and personalized medicine. Following the kick-off by Dr. Sui-Xiong Cai, Chair of the SABPA Science &Technology Committee, the keynote speaker, Dr. Nicholas J. Schork from Scripps Genomic Medicine, presented an invigorating lecture on the dramatic progress of human genome research, the hapmap project and genome-wide association studies over the last few years. Dr. Schork also discussed the resulting substantial impact on pharmacogenomics, an emerging field that has reshaped the landscape of medical field and has already prompted the FDA to consider re-labeling some of the commonly prescribed drugs. Dr. Dominic Spinella from Pfizer Inc then highlighted several key concepts and issues of applying biomarkers in drug development, especially in the oncology area. Representing Rule Based Medicine, Dr. Dominic Eisinger introduced Multi-Analyte Profiles (MAPS), an enabling technology with potential applications in protein biomarker discovery. After the break, Dr. Wen Luo from Ligand Pharmaceuticals presented a case study on applying genome-wide association to identification of genomic biomarkers for predicting patient response to bexarotene in non small cell lung cancer treatment. Dr. Michael Nerenberg from Genoptix then described a broad range of products and services available at Genoptix, which may facilitate biomarker studies and the development of diagnostic tests. Mr. Bill Harten, the final speaker of the Forum and a newcomer to the biomedical field, illustrated UNIConnect’s software and its ability to be easily customized and configured by computer-naïve end users, therefore representing an ideal solution to the evolving IT demands in personalized medicine. In the end, Dr. Xiangming Fang, President of SABPA, acknowledged the committee members, volunteers and the audience who chose to spend their Saturday participating and made the Forum a success. Attendees enjoyed top level presentations and networking opportunities. Many sponsors had active interactions with visitors and made wide business contacts for future follow-up.
2. The 4th SABPA OC/LA Annual Biomedical Forum (March 28, 2009)
The 4th SABPA OC/LA Annual Biomedical Forum was successfully held on March 28, 2009 with high-caliber speakers and full attendance from Orange County, Los Angeles and San Diego. Dr. Hengchu Cao, President of SABPA OC/LA, gave a brief introduction about the mission and vision of SABPA. Dr. Bill Tang, Associate Dean of Research at Henry Samuli School of Engineering, UC Irvine then made a warm welcome speech. Immediately following was the first session on Medical Device Innovation. The session was led by Rob Michiels, Chief Operating Officer of CoreVlave, which was recently acquired by Medtronic for more than 750 million dollars. Dr. Peter Chen presented a comprehensive overview of the cardiac rhythm management devices, neuromodulation breakthroughs and the latest innovation in integrated devices pioneered at the most recently formed St Jude Medical Center for Innovation and Strategic Collaboration. Industry innovation heavyweight, Stanton Rowe, Chief Scientific Officer of Edwards Lifescience showcased an impressive audio/video illustration introducing the world’s most disruptive technologies that truly revolutionized the society, particularly in medical care. His review of cardiac care from early development of open heart surgery to modern interventional approach to treat heart valve disease was inspirational. Following a short break, Dr. Alex Qiu introduced the next session on Trends in Global Biotech and Pharmaceutical Industry. Dr. Mitchell Brin, Senior Vice President at Allergan and Clinical Professor of Neurology at UC Irvine, presented the fascinating history and dramatic achievements of the Development of BOTOX. Dr. David Ke, Executive Scientific Director at Amgen, provided a comprehensive lecture on Transforming Basic Science to Drug Discovery by the Story of Sclerosteosis And Development of Anti-Sclerostin Monoclonal Antibody, the emerging blockbuster drug. After lunch, the Forum resumed with the first afternoon session on Global Business Operations, moderated by Scott Lopez of Biotronik. Sabing Lee of Knobbe, Martens, Olson & Bear, discussed the essentials of Intellectual Property in Commercialization of Life Sciences/Medical Devices. Cliff Guan, Senior Manager at Deloitte, reviewed Practical and Effective Tax Strategies by Surveying the Business Landscape in US and China. Dr. James Shen, Compliance Officer from FDA LA Office drew applause from audience with a lively presentation on the FDA requirements and regulations concerning medical and pharmaceutical products. Dr. Quanyin Gao of Irvine Pharmaceutical Services presented systematic approach to extractable and leachables, followed by a web review by Robert Frasier, Senior Representative from North America Representative Office of Shenzhen, on Shenzhen’s achievement in attracting business development in opening biomedical and biotech enterprises in China. Dr. Paul DeRidder of Crystal Cove Capital moderated a VC panel on Achievable Success in Venture Funding, with leading VC firms in California. Dr. Sofie Qiao, Founder of Lead Therapeutics, and Darin Chen, Managing Director of Hillcrest Venture Partners shared their successful stories of founding companies and answered challenging questions on Legal Risk Assessment for Venture Funding. Last but not least, Drs. Shouyan Lee and Chen Chen, representing China delegate from Suzhou Industrial Park (SIP), impressed the audience with beautifully landscaped park design and superb infrastructure plan to attract business innovation in SIP bioBay. Dr. Zhongping Chen concluded the conference with inviting words calling for active community support and participation in SABPA. The organizing committee expressed their sincere appreciation to volunteers and participants for their support and extended the invitation to future SABPA events (www.SABPA.org).
3. The 4th SABPA Professional and Personal Development series
When: 1:30 am - 5:00 pm, April 26th, 2009
Where: The Institute of Americas, UCSD, 10111 North Torrey Pines Rd., La Jolla, CA 92037
Lecture title: Survive and Thrive in Tough Times-How to accelerate your job search
Registration: $10 online; $15 onsite (Pre-registration by April 20 is highly encouraged) Please click here for online registration.
Speakers:
Barbara Preston, PhD, founder of PharmaScouts (http://www.pharmascouts.com/bio.html)
Ken Schmitt, Founder of TurningPoint Executive Search (http://www.turningpointsearch.net/executive_team.php)
Zhu Shen, CEO, BioForesight, SABPA Vice Chairman and Chair of Pacific Forum (http://www.bioforesight.biz/)
World economy in turmoil, stock market plunging and jobless rate 27-year low, it seems no one is escaping THE global downturn. Are you worrying about your job and feeling desperate to secure it? Have you been laid off and started to get frustrated in searching for new? Have you felt even needier to brush up your networking and communication skills? Are your resume and cover letter ready to go? Do you need to prepare for the very important interview next week? Have you ever realized that crisis may mean opportunities?
To help our members and the community to survive and thrive in the current down turn, the Education and Career Development Committee of SABPA will hold the fourth annual “Professional and Personal Development Series”. This event, first launched three years ago, addresses “softer” yet critical and often overlooked skills that have not been sufficiently covered during most of our members' formal education and career. We have invited, and will continue to invite experts, executive coaches, and renowned trainers with many years of successful real life experiences to share their knowledge and expertise with our audiences. Our mission is to foster professional growth, career improvement and personal development of our members.
We look forward to helping you systematically improve on many professional and personal skills that are important to your growth and advancement. We also welcome additional speaker referrals. Please contact: Helena Fan ar_fan727@yahoo.com.
4. The 3rd SABPA Entrepreneur Symposium
When: 5:00 pm to 7:30 pm, Saturday, May 16, 2009
Where: The Institute of Americas, UCSD, 10111 North Torrey Pines Rd., La Jolla, CA 92037
Lecture title: Challenges and opportunities of a bioentrepreneur in today's economic climate: The story of Althea technologies
Speaker: Dr. Magda Marquet, Co-founded of Althea Technologies
Registration: Free. click here for online registration.
About speaker:
Dr. Marquet is a co-founder of Althea Technologies, Inc., a San Diego company that provides services and technologies to streamline drug development. Dr. Marquet has over twenty years of experience in the biotechnology industry in the United States and Europe. She was formerly Executive Director of Pharmaceutical Development at Vical Incorporated, where she patented several novel methods for the production of clinical grade DNA for use in gene therapy and DNA vaccines. Prior to joining Vical, Dr. Marquet held management positions at Amylin Pharmaceuticals, Protein Polymer Technologies, Syntro Corporation and Transgene. Dr. Marquet is a member of the board of Directors of BIOCOM and UCSD Athena. Dr. Marquet holds a Ph.D in Biochemical Engineering from the University of Toulouse/INSA, France. Dr. Marquet has received numerous prizes throughout her career. She was the winner of the 2005 E&Y Entrepreneur of the Year award in the Life Sciences category, the 2005 UCSD Athena Pinnacle award in Technology and the 2004 Women Who Mean Business award from the San Diego Business Journal.
5. IBC’s China 2009 Pharmaceutical R&D Summit (4/7-4/9/2009 Shanghai)
The China Life Sciences Industry is Changing & You Need to Be Connected to Remain in the Game. This summit will CONNECT you to the who, where, when, what and how to conduct pharmaceutical R&D in the most resource-efficient and cost effective way. You will Join global pharmaceutical and biotech executives from around the world who want to quickly get up to speed on the current scientific advances happening in China and gain insights on China’s role in the future life science industry. You will hear from over 65 international speakers presenting new ideas and strategies on “commercial imperatives” and “maximizing China’s advantage for global and domestic pharmaceutical R&D”.
When & where: April 7-9, 2009 in Shanghai
Registration: visit www.IBCLifeSciences.com/China or call (65) 6733 5087 and Use Priority Code: IR9163SABPAE.
6. TBI journal website is launched.
Trends in Bio/Pharmaceutical Industry (TBI), is a scientific journal focused on the latest discoveries, innovations, development and trends in the various fields of life sciences, especially in research institutes and pharmaceutical and biotechnology industry. Authors of TBI are mostly, but not limited to, scientific, legal and financial professional and entrepreneurs in US with Chinese heritage. The targeted readers of TBI are researchers, scientists, entrepreneurs and senior managers in biopharmaceutical industry. TBI is published quarterly both online and in hard copies. TBI is the official journal of the Alliance of Chinese-American Biotechnology and Pharmaceutical Associations (ALL-CABPA), an alliance of 5 nonprofit organizations comprising of Chinese-American Bio/pharmaceutical Society (CABS) in San Francisco Bay Area, Sino-American Biomedical and Pharmaceutical Professionals Association (SABPA) in San Diego and Los Angeles area, Chinese Biopharmaceutical Association (CBA) in Maryland, Chinese-American BioMedical Association (CABA) in Boston area, and Seattle Chinese Biomedical Assocation (SCBA) at Seattle area. In addition, Bayhelix, an organization for business and legal professionals, is also participated in publication of TBI. The participating organizations cover the major biotechnology and biopharmaceutical industrial hubs in US with a total of over 10 thousand members from the West Coast to the East Coast of US, as well as in China. TBI also partners with leading Pharmaceutical Journals in China and distributes its online version to readers in China as well.
7. The Scientist Magazine Exclusive China Supplement Media Opportunity
The award-winning magazine “The Scientist” (its publisher Dr. Richard Gallagher spoke at SABPA Pacific Forum on Nov 8 2008) is planning to publish an exclusive China supplement issue in Nov 09, an unprecedented, exciting, large-scale media opportunity for all companies doing business in China life science industry. The China issue covers at high-level and in depth Chinese government policy/incentives, leading companies in various sectors, and cutting-edge research going on in China and cross-Pacific space, with readership exceeding 1 million worldwide. This project has the endorsement of the Chinese Ministry of Science & Technology, as well as leading Chinese life science professional organization such as SABPA and The BayHelix Group.
Here is the Ireland Life Science Supplement published in 2008, as a sample for you to see what the online version would look like:
http://www.the-scientist.com/supplement/2008-7-1/
The Scientist publisher and Dr. Zhu Shen, SABPA Vice Chairman & BioForesight CEO will be traveling in China April 6-18, meeting many confirmed sponsors/supporters, and prospective sponsors in various cities (including Beijing, Shanghai, Tianjin, Suzhou, etc.) We would be happy to meet additional sponsors/prospective sponsors via the SABPA network. For further info and scheduling, please email Dr. Zhu Shen by April 3. at bioforesight@gmail.com
8. Job listing
Job openings in Sundia, Medicilon, GenScript, VivaBiotech, Abbott, Bridge, BioDuro and more at SABPA Career section
|
|
 |
|
 |
|
|
